Univariable and multivariable odds ratios for ventricular arrhythmia of each scar determinant
| . | Multivariable . | Univariable . | ||||
|---|---|---|---|---|---|---|
| OR . | 95% CI . | P-value . | OR . | 95% CI . | P-value . | |
| Model 1 | ||||||
| ȃScar mass | 1.06 | 1.01–1.11 | 0.01 | 1.06 | 1.02–1.10 | 0.002 |
| ȃLVEF ≤35% | 1.06 | 0.09–12.37 | 0.96 | 5.37 | 0.71–40.48 | 0.10 |
| ȃLV mass | 0.99 | 0.97–1.01 | 0.49 | 1.00 | 0.99–1-02 | 0.64 |
| Model 2 | ||||||
| ȃCore mass | 1.07 | 0.97–1.18 | 0.19 | 1.09 | 1.02–1.18 | 0.02 |
| ȃLVEF ≤35% | 1.90 | 0.15–24.64 | 0.62 | |||
| ȃLV mass | 1.00 | 0.98–1.02 | 0.85 | |||
| Model 3 | ||||||
| ȃBZ mass | 1.11 | 1.03–1.20 | <0.01 | 1.11 | 1.04–1.18 | 0.001 |
| ȃLVEF ≤35% | 1.38 | 0.14–13.47 | 0.78 | |||
| ȃLV mass | 0.99 | 0.97–1.01 | 0.46 | |||
| Model 4 | ||||||
| ȃPresence of BZc | 5.40 | 1.62–18.01 | <0.01 | 5.89 | 1.85–18.72 | 0.003 |
| ȃLVEF ≤35% | 2.70 | 1.62–21.24 | 0.35 | |||
| ȃLV mass | 1.00 | 0.98–1.02 | 0.97 | |||
| Model 5 | ||||||
| ȃBZ mass ≥17.2 g and BZc | 9.68 | 2.70–34.76 | <0.001 | 9.40 | 3.26–27.13 | <0.0001 |
| ȃLVEF ≤35% | 1.08 | 0.12–9.60 | 0.95 | |||
| ȃLV mass | 0.99 | 0.97–1.01 | 0.50 | |||
| . | Multivariable . | Univariable . | ||||
|---|---|---|---|---|---|---|
| OR . | 95% CI . | P-value . | OR . | 95% CI . | P-value . | |
| Model 1 | ||||||
| ȃScar mass | 1.06 | 1.01–1.11 | 0.01 | 1.06 | 1.02–1.10 | 0.002 |
| ȃLVEF ≤35% | 1.06 | 0.09–12.37 | 0.96 | 5.37 | 0.71–40.48 | 0.10 |
| ȃLV mass | 0.99 | 0.97–1.01 | 0.49 | 1.00 | 0.99–1-02 | 0.64 |
| Model 2 | ||||||
| ȃCore mass | 1.07 | 0.97–1.18 | 0.19 | 1.09 | 1.02–1.18 | 0.02 |
| ȃLVEF ≤35% | 1.90 | 0.15–24.64 | 0.62 | |||
| ȃLV mass | 1.00 | 0.98–1.02 | 0.85 | |||
| Model 3 | ||||||
| ȃBZ mass | 1.11 | 1.03–1.20 | <0.01 | 1.11 | 1.04–1.18 | 0.001 |
| ȃLVEF ≤35% | 1.38 | 0.14–13.47 | 0.78 | |||
| ȃLV mass | 0.99 | 0.97–1.01 | 0.46 | |||
| Model 4 | ||||||
| ȃPresence of BZc | 5.40 | 1.62–18.01 | <0.01 | 5.89 | 1.85–18.72 | 0.003 |
| ȃLVEF ≤35% | 2.70 | 1.62–21.24 | 0.35 | |||
| ȃLV mass | 1.00 | 0.98–1.02 | 0.97 | |||
| Model 5 | ||||||
| ȃBZ mass ≥17.2 g and BZc | 9.68 | 2.70–34.76 | <0.001 | 9.40 | 3.26–27.13 | <0.0001 |
| ȃLVEF ≤35% | 1.08 | 0.12–9.60 | 0.95 | |||
| ȃLV mass | 0.99 | 0.97–1.01 | 0.50 | |||
BZ, border zone; BZc, BZ channels; LV, left ventricular; LVEF, LV ejection fraction; OR, odds ratio.
Univariable and multivariable odds ratios for ventricular arrhythmia of each scar determinant
| . | Multivariable . | Univariable . | ||||
|---|---|---|---|---|---|---|
| OR . | 95% CI . | P-value . | OR . | 95% CI . | P-value . | |
| Model 1 | ||||||
| ȃScar mass | 1.06 | 1.01–1.11 | 0.01 | 1.06 | 1.02–1.10 | 0.002 |
| ȃLVEF ≤35% | 1.06 | 0.09–12.37 | 0.96 | 5.37 | 0.71–40.48 | 0.10 |
| ȃLV mass | 0.99 | 0.97–1.01 | 0.49 | 1.00 | 0.99–1-02 | 0.64 |
| Model 2 | ||||||
| ȃCore mass | 1.07 | 0.97–1.18 | 0.19 | 1.09 | 1.02–1.18 | 0.02 |
| ȃLVEF ≤35% | 1.90 | 0.15–24.64 | 0.62 | |||
| ȃLV mass | 1.00 | 0.98–1.02 | 0.85 | |||
| Model 3 | ||||||
| ȃBZ mass | 1.11 | 1.03–1.20 | <0.01 | 1.11 | 1.04–1.18 | 0.001 |
| ȃLVEF ≤35% | 1.38 | 0.14–13.47 | 0.78 | |||
| ȃLV mass | 0.99 | 0.97–1.01 | 0.46 | |||
| Model 4 | ||||||
| ȃPresence of BZc | 5.40 | 1.62–18.01 | <0.01 | 5.89 | 1.85–18.72 | 0.003 |
| ȃLVEF ≤35% | 2.70 | 1.62–21.24 | 0.35 | |||
| ȃLV mass | 1.00 | 0.98–1.02 | 0.97 | |||
| Model 5 | ||||||
| ȃBZ mass ≥17.2 g and BZc | 9.68 | 2.70–34.76 | <0.001 | 9.40 | 3.26–27.13 | <0.0001 |
| ȃLVEF ≤35% | 1.08 | 0.12–9.60 | 0.95 | |||
| ȃLV mass | 0.99 | 0.97–1.01 | 0.50 | |||
| . | Multivariable . | Univariable . | ||||
|---|---|---|---|---|---|---|
| OR . | 95% CI . | P-value . | OR . | 95% CI . | P-value . | |
| Model 1 | ||||||
| ȃScar mass | 1.06 | 1.01–1.11 | 0.01 | 1.06 | 1.02–1.10 | 0.002 |
| ȃLVEF ≤35% | 1.06 | 0.09–12.37 | 0.96 | 5.37 | 0.71–40.48 | 0.10 |
| ȃLV mass | 0.99 | 0.97–1.01 | 0.49 | 1.00 | 0.99–1-02 | 0.64 |
| Model 2 | ||||||
| ȃCore mass | 1.07 | 0.97–1.18 | 0.19 | 1.09 | 1.02–1.18 | 0.02 |
| ȃLVEF ≤35% | 1.90 | 0.15–24.64 | 0.62 | |||
| ȃLV mass | 1.00 | 0.98–1.02 | 0.85 | |||
| Model 3 | ||||||
| ȃBZ mass | 1.11 | 1.03–1.20 | <0.01 | 1.11 | 1.04–1.18 | 0.001 |
| ȃLVEF ≤35% | 1.38 | 0.14–13.47 | 0.78 | |||
| ȃLV mass | 0.99 | 0.97–1.01 | 0.46 | |||
| Model 4 | ||||||
| ȃPresence of BZc | 5.40 | 1.62–18.01 | <0.01 | 5.89 | 1.85–18.72 | 0.003 |
| ȃLVEF ≤35% | 2.70 | 1.62–21.24 | 0.35 | |||
| ȃLV mass | 1.00 | 0.98–1.02 | 0.97 | |||
| Model 5 | ||||||
| ȃBZ mass ≥17.2 g and BZc | 9.68 | 2.70–34.76 | <0.001 | 9.40 | 3.26–27.13 | <0.0001 |
| ȃLVEF ≤35% | 1.08 | 0.12–9.60 | 0.95 | |||
| ȃLV mass | 0.99 | 0.97–1.01 | 0.50 | |||
BZ, border zone; BZc, BZ channels; LV, left ventricular; LVEF, LV ejection fraction; OR, odds ratio.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
